99 results match your criteria: "Centre Hospitalier Départemental de Vendee[Affiliation]"

A simple prognostic score to predict recurrence after pancreaticoduodenectomy for ampullary carcinoma: results from the French prospective FFCD-AC cohort.

ESMO Open

December 2024

Institut du Cancer Paris CARPEM, APHP, Hepatogastroenterology and GI Oncology Department, APHP Centre-Université Paris Cité, Hôpital Européen G. Pompidou, Paris, France. Electronic address:

Background: Ampullary carcinoma (AC) is a rare and severe gastrointestinal cancer with a disease recurrence rate of around 40% after curative-intent surgery and for which the main prognostic factors and adjuvant treatment decision remain a matter of debate.

Patients And Methods: The FFCD-AC cohort is a French nationwide prospective cohort, which included patients with non-metastatic resected AC. The primary objective of this study was to describe prognostic factors associated with disease-free survival (DFS) and overall survival (OS) after pancreaticoduodenectomy (PD) so as to propose a user-friendly score to better estimate the risk of recurrence.

View Article and Find Full Text PDF

[Thinking about family carers in terms of their experiential knowledge].

Soins Psychiatr

June 2024

Établissement public de santé mentale de Vendée, Centre hospitalier Georges-Mazurelle, rue d'Aubrigny, 85000 La Roche-sur-Yon, France; Nantes Université, CHU Nantes, Mouvement - Interactions - Performance, MIP, UR 4334, F-44000 Nantes, France. Electronic address:

Despite well-established recommendations and psycho-education programmes, the health of family carers is most often impaired, which means that the support they provide is seen only in terms of burden. A phenomenological approach based on strength-based care shows that they develop skills and strategies for the well-being of their loved one, and are nurtured by a sense of hope that enables them to acquire experiential knowledge.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined whether Mas-receptor activation by BIO101 could help balance the Renin-Angiotensin System and reduce severe respiratory issues in hospitalized COVID-19 patients.
  • It was a double-blind, randomized trial involving 238 participants, with findings showing a 11.4% lower rate of respiratory failure or early death in the BIO101 group compared to placebo.
  • Results suggest BIO101 may reduce the risk of severe outcomes in COVID-19 patients, although further research is needed due to the low sample size.
View Article and Find Full Text PDF

Costs and resource utilization patterns in surgical site infections: a pre-COVID-19 perspective from France, Germany, Spain, and the UK.

J Hosp Infect

May 2024

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn-Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology, University of Cologne, Cologne, Germany; FOM University of Applied Sciences, Essen, Germany.

Background: Surgical site infections (SSIs), mainly caused by Staphylococcus aureus, pose a significant economic burden in Europe, leading to increased hospitalization duration, mortality, and treatment costs, particularly with drug-resistant strains such as meticillin-resistant S. aureus.

Aim: To conduct a case-control study on the economic impact of S.

View Article and Find Full Text PDF

Background: Endotracheal tube fixation in ventilated patients must be appropriate to ensure security during mechanical ventilation and prevent skin lesions. The incidence of endotracheal tube-caused pressure ulcers ranges from 7% to 45%. Various endotracheal tube fixations are used in intensive care units (ICUs) worldwide.

View Article and Find Full Text PDF

Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial.

Lancet Respir Med

May 2024

Department of Intensive Care, Raymond Poincaré Hospital, APHP University Versailles Saint Quentin-University Paris Saclay, Garches, France; Institut Hospitalo Universitaire PROMETHEUS, Garches, France; Laboratory of Infection & Inflammation-U1173, School of Medicine, INSERM, University Versailles Saint Quentin-University Paris Saclay, Garches, France; FHU SEPSIS, Garches, France. Electronic address:

Article Synopsis
  • The study explores the effectiveness of hydrocortisone and fludrocortisone treatments in patients with septic shock caused by community-acquired pneumonia (CAP) compared to non-CAP cases.
  • It includes data from the phase 3 APROCCHSS trial, which initially tested these treatments across multiple centers in France, focusing specifically on how they impact mortality outcomes.
  • Results indicate that patients with CAP may respond differently to these treatments, and various mortality rates and recovery metrics were analyzed to determine the overall benefit of the steroid regimen.
View Article and Find Full Text PDF

The France PCI registry: Design, methodology and key findings.

Arch Cardiovasc Dis

November 2023

Sorbonne Université, Action Study Group (action-groupe.org), Institut de Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, 75013 Paris, France.

Background: Obstructive coronary artery disease is the main cause of death worldwide. By tracking events and gaining feedback on patient management, the most relevant information is provided to public health services to further improve prognosis.

Aims: To create an inclusive and accurate registry of all percutaneous coronary intervention (PCI) procedures performed in France, to assess and improve the quality of care and create research incentives.

View Article and Find Full Text PDF

Objective: To determine the overall and procedure-specific incidence of surgical site infections (SSI) caused by Staphylococcus aureus (S. aureus) as well as risk factors for such across all surgical disciplines in Europe.

Methods: This is a retrospective cohort of patients with surgical procedures performed at 14 European centres in 2016, with a nested case-control analysis.

View Article and Find Full Text PDF

[Hypnotic pain management during ultrasound-guided infiltration of the hand].

Rev Infirm

November 2023

Centre hospitalier départemental de Vendée, Service de rhumatologie, Les Oudairies, Boulevard Stéphane-Moreau, 85000 La Roche-sur-Yon, France. Electronic address:

Ultrasound-guided infiltration, performed to relieve pain, is a common and sometimes painful procedure, particularly on the hand. This potential pain, induced by the treatment, can cause apprehension in patients prior to such a procedure. The rheumatology team at the departmental hospital center (CHD) in Vendée hypothesized that a hypnosis session, by creating an imaginary glove on the patient's painful hand prior to the procedure, could help reduce the pain felt, as well as anxiety.

View Article and Find Full Text PDF

Cognitive functions enable us to receive, select, store, transform, process and retrieve the information we receive from the outside world. These functions are controlled by different brain structures that interact with each other, enabling us to interact with and understand the world around us. In the course of aging or the onset of neurocognitive diseases, these functions may be impaired to a greater or lesser extent, giving rise to a considerable variety of neurocognitive impairment profiles.

View Article and Find Full Text PDF

Background: Activation of the TREM-1 pathway is associated with outcome in life threatening COVID-19. Data suggest that modulation of this pathway with nangibotide, a TREM-1 modulator may improve survival in TREM-1 activated patients (identified using the biomarker sTREM-1).

Methods: Phase 2 double-blind randomized controlled trial assessing efficacy, safety, and optimum treatment population of nangibotide (1.

View Article and Find Full Text PDF

Background: Activation of the triggering receptor expressed on myeloid cells-1 (TREM-1) pathway is associated with septic shock outcomes. Data suggest that modulation of this pathway in patients with activated TREM-1 might improve survival. Soluble TREM-1 (sTREM-1), a potential mechanism-based biomarker, might facilitate enrichment of patient selection in clinical trials of nangibotide, a TREM-1 modulator.

View Article and Find Full Text PDF

Purpose: Infectious encephalitis (IE) is a severe disease which requires intensive care unit (ICU) admission in up to 50% of cases. We aimed to describe characteristics, management and outcomes of IE patients who required ICU admission.

Materials And Methods: Ancillary study focusing on patients with ICU admission within the ENCEIF cohort, a French prospective observational multicentre study.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with severe COVID-19 in ICUs have a high risk of blood clots, prompting a study to compare the effects of intermediate-dose versus standard-dose anticoagulation.
  • The study included 1,174 patients and found no significant difference in 90-day mortality or ICU stay length between the two dosing groups, but intermediate-dose patients had fewer venous thrombo-embolism (VTE) incidents.
  • Both groups experienced similar rates of bleeding complications, indicating that while the doses impacted blood clot rates, they did not affect overall survival or safety.
View Article and Find Full Text PDF

Hydrocortisone in Severe Community-Acquired Pneumonia.

N Engl J Med

May 2023

From Université de Tours, INSERM, Center for the Study of Respiratory Diseases Unité 1100, Médecine Intensive-Réanimation and INSERM Centre d'Investigation Clinique 1415, Centre Hospitalier Universitaire (CHU) (P.-F.D.), Délégation à la Recherche Clinique et à l'Innovation, CHU (M.L., C.C.), Pharmacie à Usage Interne, CHU (H.B.), Centre Régional de Pharmacovigilance et d'Information sur le Médicament, Service de Pharmacosurveillance, CHU (C.L.), Université de Tours, Université de Nantes, INSERM SPHERE Unité 1246 (B.G.), and INSERM Centre d'Investigation Clinique 1415, CHU (B.G., A.L.G.), Tours, INSERM, Unité Mixte de Recherche 1260, Regenerative Nanomedicine, Université de Strasbourg, Faculté de Médecine, and Médecine Intensive-Réanimation Nouvel Hôpital Civil (F.M.), Médecine Intensive Réanimation, Hôpital de Hautepierre (J.-E.H.), Hôpitaux Universitaires de Strasbourg, Strasbourg, the Lipness Team, INSERM Lipids, Nutrition, Cancer-Unité Mixte de Recherche 1231 and LabEx LipSTIC, INSERM Centre d'Investigation Clinique 1432, Clinical Epidemiology, Université de Bourgogne, and Médecine Intensive Réanimation, CHU (J.-P.Q.), Dijon, Médecine Intensive Réanimation, Hôpital de la Source, Orléans (T.K.), INSERM Infection, Antimicrobials, Modeling, and Evolution (IAME) Unité 1137, Université Paris Cité (J.-D.R.), Sorbonne Université, Centre de Recherche Saint-Antoine Unité Mixte de Recherche 938 INSERM, Médecine Intensive Réanimation, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Tenon (G.V.), and Université Paris Cité, Paris, Médecine Intensive Réanimation, AP-HP, Hôpital Cochin (J.-P.M.), Médecine Intensive Réanimation, DMU ESPRIT, Colombes (J.-D.R.), Réanimation Polyvalente, Hôpital Nord Franche-Comté, Trévenans (J.B.), Université de Nantes et Médecine Intensive-Réanimation, Hôtel-Dieu, Nantes (J.R.), Fédération Hospitalo Universitaire (FHU) SEPSIS, INSERM Unité 1173, Faculté de Médecine Simone Veil, Université Versailles Saint Quentin, Université de Paris Saclay, and Médecine Intensive-Réanimation, AP-HP, Hôpital Raymond Poincaré (N.H.), Garches, Réanimation Polyvalente, CH Victor Dupouy, Argenteuil (G.P.), Université Clermont Auvergne Unité Mixte de Recherche, French National Center for Scientific Research (CNRS) 6023, Laboratoire Microorganismes: Génome Environnement and Médecine Intensive Réanimation, CHU Clermont-Ferrand, Clermont-Ferrand (B.S.), Médecine Intensive Réanimation, Centre Hospitalier Départemental de Vendée, La Roche-Sur-Yon (G.C.), INSERM Centre d'Investigation Clinique 1402, Investigations of Sleep, Acute Lung Injury, and Ventilation, Université de Poitiers, Faculté de Médecine et de Pharmacie de Poitiers, and Médecine Intensive Réanimation, CHU (J.-P.F.), Poitiers, Réanimation, Centre Hospitalier, Saint Brieuc (N.B.), Unité Mixte de Recherche 1092, Université, Limoges, and INSERM Centre d'Investigation Clinique 1435 and Réanimation Polyvalente, CHU (B.F.), Limoges, Réanimation Polyvalente, Hôpital de Mercy, Centre Hospitalier Régional (CHR) Metz-Thionville, Metz (G.L.), Université de Lorraine, and Médecine Intensive Réanimation, Hôpital Central, CHU, Nancy (S.G.), Réanimation Médico-Chirurgicale, Hôpital, Le Mans (C. Guitton), Réanimation Polyvalente, Hôpital d'Instruction des Armées Clermont Tonnerre (C. Giacardi), Laboratoire de Traitement de l'Information Médicale INSERM Mixte de Recherche Unité 1101, Université de Bretagne Occidentale (E.L.), and Médecine Intensive Réanimation, CHU de la Cavale Blanche (E.L.), Brest, Aix-Marseille Université, Health Service Research and Quality of Life Center, the Department of Medical Information, Assistance Publique-Hopitaux de Marseille (AP-HM), Marseille, and Médecine Intensive-Réanimation, AP-HM, Hôpital Nord, Marseille (S.H.), Réanimation, Centre Hospitalier, Montauban (S.V.), Médecine Intensive Réanimation, Centre Hospitalier Intercommunal Robert Ballanger, Aulnay-Sous-Bois (H.F.), Réanimation, Centre Hospitalier, Bourg-en-Bresse (C.B.), Médecine Intensive Réanimation, CHU, Caen (A.J.), INSERM Unité 1042, HP-2, Université Grenoble-Alpes, and Médecine Intensive Réanimation, CHU Grenoble Alpes, Grenoble (N.T.), Maladies Infectieuses et Réanimation Médicale, Hôpital Pontchaillou, Rennes (A.G.), Réanimation, Centre Hospitalier, Saint-Malo (C.Q.), INSERM Unité 1190, Université de Lille, and the Département de Réanimation, Hôpital Roger Salengro, CHU, Lille (M.J.), and INSERM Centre d'Investigation Clinique 1435, CHU, Limoges (C.C.-F.) - all in France.

Article Synopsis
  • A phase 3 clinical trial investigated if intravenous hydrocortisone could reduce mortality in patients with severe community-acquired pneumonia compared to a placebo.
  • The study involved 800 patients, and results showed that those receiving hydrocortisone had a significantly lower death rate (6.2%) at 28 days versus 11.9% in the placebo group.
  • Additionally, patients on hydrocortisone required less mechanical ventilation and vasopressors compared to those on placebo, with similar rates of hospital-acquired infections and bleeding risks.
View Article and Find Full Text PDF
Article Synopsis
  • The RECORDS trial investigates how different adult patients with sepsis respond to corticosteroids by categorizing them into distinct groups based on their likelihood of responding to treatment.
  • It is a large, placebo-controlled study that includes 1800 adults with conditions like pneumonia and septic shock, randomly assigning them to receive either corticosteroids or placebo for 7 to 10 days.
  • The primary goal is to assess the impact of corticosteroids on mortality and organ dysfunction after 90 days, with the findings expected to be shared at conferences and published in scientific journals.
View Article and Find Full Text PDF

Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study.

Eur J Cancer

March 2023

Departement of Medical Oncology, Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, APHP-Centre, Université Paris Cité, Service d'oncologie médicale, 20 rue Leblanc, 75015, Paris, France. Electronic address:

Introduction: Bone metastases (BM) in renal cell carcinoma (RCC) are associated with a poor prognosis based on retrospective studies evaluating antiangiogenic agents. Few data are available regarding immune checkpoint inhibitors (ICI) in patients with bone metastatic RCC. NIVOREN is a multicentre prospective study in which patients were treated with nivolumab after the failure of antiangiogenic agents.

View Article and Find Full Text PDF

Background: Generalised convulsive status epilepticus (GCSE) is a medical emergency. Guidelines recommend a stepwise strategy of benzodiazepines followed by a second-line anti-seizure medicine (ASM). However, GCSE is uncontrolled in 20-40% patients and is associated with protracted hospitalisation, disability, and mortality.

View Article and Find Full Text PDF

Background: Honey is described as a wound healing agent. Many virtues have been attributed to it, in particular, antibacterial properties. The aim of our study was to evaluate its value in healing of wounds after wide excision on pilonidal cyst healing.

View Article and Find Full Text PDF

Background: To evaluate potential synergistic effect of pembrolizumab with radiotherapy (RT) compared with a standard-of-care (SOC) cetuximab-RT in patients with locally advanced-squamous cell carcinoma of head and neck (LA-SCCHN).

Patients And Methods: Patients with nonoperated stage III-IV SCC of oral cavity, oropharynx, hypopharynx, and larynx and unfit for receiving high-dose cisplatin were enrolled. Patients received once-daily RT up to 69.

View Article and Find Full Text PDF

[Thinking about care to enhance its meaning].

Soins

October 2022

Département des instituts de formation du centre hospitalier universitaire de Nantes, 5 allée de l'Île-Gloriette, 44093 Nantes cedex 1, France; UFR Médecine et techniques médicales, Université de Nantes, 1 rue Gaston-Veil, BP 53508, 44035 Nantes cedex 1, France.

Advanced nursing practice is one of the avenues proposed by politicians to meet the new needs of people being cared for in a rapidly changing healthcare system. It is therefore interesting to conceptualize the theoretical foundations of these new practices, in order to reveal their meaning. To do this, we will discuss some of the missions of the advanced practice nurse, whose primary objective is to provide high-quality care.

View Article and Find Full Text PDF
Article Synopsis
  • Immunotherapy that uses the body's immune system is becoming popular in treating blood cancers like mantle cell lymphoma (MCL), but there's little understanding of immune cell behavior in MCL patients' lymph nodes and bone marrow.
  • The study utilized a technique called RT-MLPA to analyze gene expression in MCL patients at diagnosis and relapse, focusing on immune-related genes to gain insights into tumor aggressiveness and immune response.
  • Results showed that aggressive MCL forms had increased macrophage-related gene expression but lower T-cell markers, which could help differentiate between patient groups and guide personalized treatment approaches.
View Article and Find Full Text PDF

Spontaneous-Breathing Trials with Pressure-Support Ventilation or a T-Piece.

N Engl J Med

November 2022

From Centre Hospitalier Universitaire (CHU) de Poitiers, Médecine Intensive Réanimation (A.W.T., R.C., J.-P.F.), and Institut National de la Santé et de la Recherche Médicale (INSERM) Centre d'Investigation Clinique (CIC) 1402, Investigations of Sleep, Acute Lung Injury, and Ventilation (IS-ALIVE), Université de Poitiers (A.W.T., R.C., J.K., S.R., J.-P.F.), Poitiers, CHU de Rennes, Hôpital Pontchaillou, Service des Maladies Infectieuses et Réanimation Médicale, Rennes (A.G.), Centre Hospitalier Régional Universitaire de Tours, Médecine Intensive Réanimation, INSERM CIC 1415, Critical Research in Intensive Care and Sepsis-TriggerSep Research Network, and Centre d'Etude des Pathologies Respiratoires, INSERM U1100, Université de Tours, Tours (S.E.), CHU Dijon Bourgogne, Médecine Intensive Réanimation, INSERM CIC 1432, Université de Bourgogne Franche-Comté, Dijon (J.-P.Q.), Centre Hospitalier Régional d'Orléans, Médecine Intensive Réanimation, Orléans (M.-A.N.), Centre Hospitalier du Mans, Réanimation Médico-Chirurgicale, Le Mans (C.G.), Centre Hospitalier Victor Dupouy, Réanimation Polyvalente et Unité de Surveillance Continue, Argenteuil (D.C.), Groupe Hospitalier Régional Mulhouse Sud Alsace, site Emile Muller, Service de Réanimation Médicale, Mulhouse (G. Labro), CHU de Nantes, Médecine Intensive Réanimation, Nantes (J.R.), Centre Hospitalier Henri Mondor d'Aurillac, Service de Réanimation, Aurillac (G. Pradel), CHU de Rouen, Hôpital Charles Nicolle, Département de Réanimation Médicale, Normandie Université, Université de Rouen UR3830, Rouen (G.B.), CHU Félix Guyon, Service de Réanimation Polyvalente, Saint Denis de la Réunion (L.D.), CHU de Nice, Réanimation Médicale Archet 1, UR2CA-Unité de Recherche Clinique Côte d'Azur, Université Côte d'Azur, Nice (C.S.), CHU de Brest, Médecine Intensive Réanimation, Brest (G. Prat), Centre Hospitalier de Versailles, Service de Réanimation Médico-Chirurgicale, Le Chesnay (G. Lacave), Centre Hospitalier Fleyriat de Bourg-en-Bresse, Réanimation Polyvalente, Bourg-en-Bresse (N.S.), CHU Grenoble Alpes, Médecine Intensive Réanimation, INSERM U1042, HP2, Université Grenoble Alpes, Grenoble (N.T.), Centre Hospitalier Bretagne Sud, Réanimation Polyvalente, Lorient (B.L.C.), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Paris Centre, Hôpital Cochin, Médecine Intensive Réanimation, Université Paris Cité, Institut Cochin, Centre National de la Recherche Scientifique (CNRS) Unité Mixte de Recherche (UMR) 8104, INSERM U1016 (J.-P.M.), and AP-HP, Groupe Hospitalier Universitaire AP-HP-Sorbonne Université, site Pitié-Salpêtrière, Service de Médecine Intensive-Réanimation, Département R3S (M.D.), Paris, Centre Hospitalier de Pau, Service de Réanimation, Pau (A. Romen), Centre Hospitalier Départemental de Vendée, Médecine Intensive Réanimation, La Roche Sur Yon (M.-A.A.), CHU de Lille, Médecine Intensive Réanimation, CNRS UMR 8576, INSERM U1285, Université de Lille, Lille (A. Rouzé), Hôpital Foch, Service de Réanimation Polyvalente, Suresnes (J.D.), Centre Hospitalier Bretagne Atlantique, Réanimation Polyvalente, Vannes (A.D.), Assistance Publique-Hôpitaux de Marseille, CHU La Timone 2, Médecine Intensive Réanimation, Réanimation des Urgences, Aix-Marseille Université, Marseille (J.B.), and Centre Jean Perrin, Unicancer, Service de Réanimation, Clermont-Ferrand (A.L.) - all in France.

Background: Spontaneous-breathing trials can be performed with the use of either pressure-support ventilation (PSV) or a T-piece. Whether PSV trials may result in a shorter time to tracheal extubation than T-piece trials, without resulting in a higher risk of reintubation, among patients who have a high risk of extubation failure is unknown.

Methods: In this multicenter, open-label trial, we randomly assigned patients who had a high risk of extubation failure (i.

View Article and Find Full Text PDF

[Advanced practice nursing in psychiatry and mental health].

Soins Psychiatr

October 2022

Pôle Littoral 2 de psychiatrie adulte, EPSM de Vendée, Centre hospitalier Georges-Mazurelle, 85026 La Roche-sur-Yon cedex, France.

With more than 500 advanced practice nurses in psychiatry and mental health (APN-PMH) graduating by 2023, this new profession is shaking up the codes of interprofessional functioning and the care of people suffering from mental disorders. It seems important to shed some light on the issues involved in the implementation of the APN, but also to present the training, roles and certain theoretical inspirations that make the APN-PMH a multicultural actor in care.

View Article and Find Full Text PDF